Monday, March 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

GAO Recommends Homeland Security Conduct Bioforensic Gap Analysis

by Global Biodefense Staff
February 13, 2017
Bioterrorism & Biodefense

The ability to attribute the source of an intentionally released biological threat agent and quickly apprehend and prosecute the perpetrator is essential to our nation’s safety. However, questions remain about whether Department of Homeland Security (DHS) and Federal Bureau of Investigation (FBI) capabilities have improved since the 2001 anthrax attack.

A new assessment by the U.S. Government Accountability Office (GAO) advises the DHS to conduct a formal bioforensics capability gap analysis to more accurately identify needs in bioforensics capabilities to help guide current and future investments.

GAO’s review focused on the agencies’ efforts since 2010, when the FBI’s investigation of the 2001 anthrax attack was closed. GAO analyzed relevant agency documents and interviewed agency officials and scientists on issues related to bioforensics. GAO also convened a meeting of experts with NAS’s assistance to discuss potential bioforensics needs.

Both DHS and FBI have identified some gaps in their bioforensics capabilities, but have not performed an adequate formal analysis, leaving a number of questions on the scope of deficiencies and how to effectively priorities acquisitions to address those gaps.

DHS held informal meetings to seek FBI input on capability gaps associated with recent casework. Gaps identified through this informal process include the inability to characterize unique, novel, and engineered agents and “unknowns” and to understand and communicate uncertainty associated with analyzing complex biological samples, among other things.

According to the GAO, the absence of a well-documented bioforensics capability gap analysis, the rationale for DHS’s resource allocations, or its plans for future enhancements to existing capabilities are not clear and thus cannot ensure that resources are being targeted to the highest priority gaps.

In addition to DHS and the FBI, other organizations, such as the National Research Council (NRC) of the National Academy of Sciences (NAS), and the National Science and Technology Council (NSTC) of the Office of Science and Technology Policy (OSTP), have identified potential bioforensics capability needs. These needs can generally be grouped into three areas: science, technology and methods, and bioinformatics and data.

GAO also convened a meeting of experts, with the help of NAS, and these experts updated a list of potential bioforensics capability needs that NAS and OSTP had previously identified within each of these areas. Some of the needs these experts confirmed as still relevant were similar to those DHS and FBI officials have identified, while others were different.

For example, like DHS and the FBI, the experts agreed that an ability to characterize genetically engineered agents was needed, but they also suggested that evaluating existing protocols, such as those for DNA sequencing, to determine whether they were validated, was needed.

GAO believes that this information may be helpful to DHS and the FBI as part of any future bioforensics capability gap analysis they undertake.

Read the full report: DHS Needs to Conduct a Formal Capability Gap Analysis to Better Identify and Address Gaps (Feb 2017).

Tags: Forensics

Related Posts

New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Researcher holds a pipette
Biodetection

These Nanotech Bubbles Burst When They Detect Viruses in the Air

October 25, 2022
Influenza Research
Biodetection

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC